Global Innovative Concepts, LLC v. State of Florida, Division of Emergency Management

CourtDistrict Court, E.D. North Carolina
DecidedJuly 15, 2025
Docket5:23-cv-00069
StatusUnknown

This text of Global Innovative Concepts, LLC v. State of Florida, Division of Emergency Management (Global Innovative Concepts, LLC v. State of Florida, Division of Emergency Management) is published on Counsel Stack Legal Research, covering District Court, E.D. North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Global Innovative Concepts, LLC v. State of Florida, Division of Emergency Management, (E.D.N.C. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NORTH CAROLINA WESTERN DIVISION

NO. 5:23-CV-69-FL

GLOBAL INNOVATIVE CONCEPTS, ) LLC; A.I. FIRST ALABAMA, LLC; and ) ALLEN KILGORE, ) ) ) Plaintiffs/Counterclaim Defendants, ) ) ORDER v. ) ) STATE OF FLORIDA, DIVISION OF ) EMERGENCY MANAGEMENT, ) ) ) Defendant/Counterclaim Plaintiff. )

This matter is before the court on the parties’ supplemental briefs following remand from the United States Court of Appeals for the Fourth Circuit (DE 51, 52). The Fourth Circuit left for decision on remand a fact-intensive dispute regarding the contracts at issue, explained in more detail below. The court adopted a consent discovery and briefing schedule from the parties, which produced the instant supplemental briefs. In this posture, the court regards these briefs, which follow a discovery period and rely upon materials produced therein, and address a dispositive question, as motions for summary judgment. For the following reasons, defendant’s motion is granted, and plaintiffs’ is denied. STATEMENT OF THE CASE Plaintiffs commenced this action February 15, 2023, with claims arising out of two transactions in 2020 between Essential Diagnostics, LLC (“Essential”), a North Carolina business, and defendant for the purchase of 600,000 COVID test kits. Plaintiffs provide in their complaint that Essential assigned its legal claims against defendant to plaintiffs, two Alabama corporations and a resident of Alabama. Plaintiffs seek damages, costs, and interest. Defendant moved to dismiss March 9, 2023, on the basis of, inter alia, its Eleventh Amendment sovereign immunity, and in the alternative to transfer venue on grounds that plaintiff

Global Innovative Concepts, LLC’s (“Global”) complaint in Florida state court asserted claims premised upon the same conduct by defendant, the state court’s order of dismissal permitting plaintiff time to file an amended complaint, and plaintiff Global’s subsequent notice of voluntary dismissal. On September 21, 2023, this court denied defendant’s motion to dismiss. Defendant filed an interlocutory appeal of the court’s ruling on its immunity to suit under the Eleventh Amendment, after which the Fourth Circuit vacated and remanded this court’s order. The Fourth Circuit concluded that this court erred in determining that defendant waived its Eleventh Amendment immunity by the mere entry into the contracts at issue, and remanded for an evaluation

of plaintiffs’ “fallback argument” that defendant agreed to a forum selection clause specifying this court, and if so, whether that clause sufficed to waive defendant’s immunity. (Fourth Circuit Op. (DE 38) 9); see Glob. Innovative Concepts, LLC v. State of Fla., Div. of Emergency Mgmt., 105 F.4th 139, 144 (4th Cir. 2024). Following remand, the parties engaged in discovery limited to those questions, and in accordance with a consent briefing schedule, filed supplemental briefs on those two issues. Said briefing is now complete. Both sides rely on numerous depositions, pre-suit communications between the parties, and documentation of the parties’ transactions. STATEMENT OF FACTS The facts alleged in plaintiffs’ complaint may be summarized as follows.1 On March 22, 2020, defendant entered into an agreement with Essential for the purchase of 200,000 COVID viral sample collection kits for $2,200,000.00. (Compl. (DE 1) ¶ 10). That agreement was recorded in a purchase form (the “first purchase order”). (Id.).

The first purchase order includes a clause providing that the agreement “shall be governed by and construed and enforced in accordance with the laws of the State of North Carolina” and “[a]ll disputes with respect to [it] shall be brought and heard either in the North Carolina state courts located in Wake County, North Carolina, or the federal district court for the Eastern District of North Carolina[.]” (Id. ¶ 11). It also provides that the “Terms and Conditions of Sale and the Purchase Agreement . . . govern the sale of all Seller’s products [] to Buyer” and “[a]ny terms proposed by Buyer, which add to, vary from, or conflict with the terms of the Agreement shall be void, and the terms of the Agreement shall govern.” (Id. ¶ 12). Finally, it states: This Agreement and any acknowledgement or acceptance of a purchase order by Seller constitute the complete and exclusive statement of the agreement between the parties regarding the subject matter hereof and supersede all proposals, oral or written, and all other communications between the parties relating to the subject matter herein.

(Id. ¶ 14). Plaintiffs Global, A.I. First Alabama (“AI First”), and Alan Kilgore (“Kilgore”), a principal and officer of both Global and AI First, were agents of Essential. (Id. ¶ 23). Essential, Global, and Kilgore “invested significant time, efforts, and costs to procure the COVID test kits” under the first purchase order, and on April 3, 2020, Essential delivered the 200,000 COVID test

1 The court recounts the facts not contradicted by the parties’ evidence in this section only for background purposes, and discusses the facts that are relevant to the legal issues resolved in this order as they become relevant to each issue in turn below. kits to defendant in Tallahassee, Florida. (Id. ¶¶ 16-17). Defendant confirmed receipt of the tests, and that the tests had been “vetted and cleared” by Florida State University Laboratories and by “FLDOH.” (Id. ¶ 18). Pursuant to the terms of the signed purchase form, defendant was obliged to pay the total purchase amount of $2,200,000.00 for the first purchase order within 45 days of delivery, or by May 18, 2020. (Id. ¶ 19). Defendant has not made a payment under the first

purchase order. (Id.). On March 24, 2020, two days after signing the first purchase order, defendant contacted Kilgore and requested additional COVID test kits from Essential. (Id. ¶ 22). Kilgore, on behalf of Essential, offered to provide an additional 400,000 test kits for $4,400,000.00. (Id. ¶ 24). Kilgore sent defendant a purchase order with terms identical to those identified in the first purchase order, but with the additional requirement that defendant pay half the total invoice up front with the remainder due within 45 days of delivery (the “second purchase agreement”). (Id. ¶¶ 25, 30). Defendant responded by email expressing interest in “swabs” and thereafter with a signed letter on defendant’s letterhead confirming payment of $2,200,000.00 for the purchase of 400,000

testing kits, and providing that the balance of $2,200,000.00 would be paid within 45 days of receipt of the kits. (Exhibit D (DE 1-4); Exhibit E (DE 1-5)). Plaintiffs again “invested significant time, efforts, and costs to procure the COVID tests” under the second purchase agreement, and by April all 400,000 test kits were ready to be delivered to defendant in Tallahassee, Florida. (Compl. ¶ 31). Around April 16, 2020, however, defendant “attempted to terminate [the second purchase agreement] based upon [defendant’s] purported convenience.” (Id. ¶ 32). Defendant also thereafter alleged that the test kits delivered under the first purchase agreement were defective, despite earlier confirming that they had been vetted and cleared by Florida State University Laboratories and by “FLDOH.” (Id.). Defendant’s director of legal affairs also had previously communicated with plaintiffs that he had verified other states were successfully using the same test kits. (Id. ¶ 33). Several labs in Florida likewise were using them. (Id.). Plaintiffs sought a discussion with defendant to alleviate concerns and provided defendant with confirmation of the successful use of the test kits in Florida. (Id. ¶ 34). Defendant responded

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Global Innovative Concepts, LLC v. State of Florida, Division of Emergency Management, Counsel Stack Legal Research, https://law.counselstack.com/opinion/global-innovative-concepts-llc-v-state-of-florida-division-of-emergency-nced-2025.